LSUHSC Renal Pathology Consultative
Services - Case Study #2
| Case Study #: 2007
0226 |
| Clinical History: |
|
A
86-year old male presented with decrease urine output
and dark urine. He was afebrile,
mildly hypertensive at 145/95. No systemic symptoms were
present and he had no pertinent past renal-related
medical history. No medicines had recently been
introduced.
Laboratory values were as follows:
Urinalysis: 3+
hematuria
3+
proteinuria
Numerous
rbc casts
Creatinine:
7.2 mg/dl
C3/C4 – normal
Hepatitis B and C – negative
ANA negative
ANCA and AGBM
serologies pending |

Click for larger |
Figure 1:
Although difficult to recognize 2
glomeruli are
present both show global necrosis with abundant
fibrin deposition and cellular crescent
formation. |

Click for larger |
Figure 2:
Silver stain of one
glomerulus shows that only a few remnants
of capillary loop basement membranes remain. |

Click for larger |
Figure 3:
Direct immunofluorescence is required to
resolve the differential of a
crescentic
glomerulonephritis
(linear vs. granular vs. negative
immunofluorescence) and
serologies are necessary to confirm the
IF findings. However, this
glomerulus contains a finding that has an
extremely high correlation with the specific
diagnosis. You may be surprised by the
correlation. |
| |
|
|
Question: |
What
is the diagnostic finding?
What
diagnosis does it strongly suggest? |
|
Answer: |
|
|
Diagnosis: |
-
Multinucleated giant cell
- Anti-glomerular
basement membrane antibody-associated
crescentic
glomerulonephritis
|
|
Discussion: |
The
presence of a well form multinucleated giant cell in a
crescentic
glomerulonephritis, in my
experience, is invariably associated with a linear IF
and serologically confirmed AGBM antibody. This may seem
surprising since a giant cell reaction is what you might
expect for a granulomatous
vasculitis, like Wegener’s
granulomatosis, involving
the kidney. However, the
granulomatous component in Wegener’s is usually
limited to ENT and lung lesions. The presence of giant
cells in AGBM has been reported (Nephron
16: 415, 1976) and is illustrated in the 6th
edition of Heptinstall’s
Pathology of the Kidney (figure 13-14). Although it
has never been emphasized as a useful diagnostic feature
(probably because with IF and serology the diagnosis is
never in doubt), I believe its specificity and
sensitivity is over 90%. In fact, I can’t recall a case
of AGBM disease in the last several years that lacked
giant cells, or a case with giant cells that did not
turn out to be AGBM-mediated disease (sounds like a
notion that merits investigation). |
|
References: |
General references on AGBM disease and
Goodpasture’s syndrome:
Kidney Int
64:1535-1550, 2003.
J Am Soc Nephrol
10:244-2453, 1999.
|
|
Stephen M. Bonsib,
MD (Dr
Bonsib's Bio)
Chairman Pathology
Director, Renal
Pathology Consultative Services
Albert G. and Harriet
G. Smith Professor of Pathology
See a few of our case studies... and Contact Us for more
information.
 |